Monitor heart rate and BP continuously during administration. Slow or discontinue if BP drops excessively.
Monitor intake and output and daily weight. Assess patient for resolution of signs and symptoms of HF (peripheral edema, dyspnea, rales/crackles, weight gain) and improvement in hemodynamic parameters (increase in cardiac output and cardiac index, decrease in pulmonary capillary wedge pressure). Correct effects of previous aggressive diuretic therapy to allow for optimal filling pressure.
Monitor ECG continuously during infusion. Arrhythmias are common and may be life threatening. The risk of ventricular arrhythmias is increased in patients with a history of arrhythmias, electrolyte abnormalities, abnormal digoxin levels, or insertion of vascular catheters.
Lab Test Considerations:
Monitor electrolytes and renal function frequently during administration. Correct hypokalemia prior to administration to decrease the risk of arrhythmias.
Monitor platelet count during therapy.
Toxicity and Overdose:
High Alert: Overdose manifests as hypotension. Dose should be decreased or discontinued. Supportive measures may be necessary.
High Alert: Accidental overdose of milrinone can cause patient harm or death. Have second practitioner independently check original order, dose calculations, and infusion pump settings.
IV Push: Dilution: Loading dose may be administered undiluted. May also be diluted in 0.9% NaCl, 0.45% NaCl, or D5W for ease of administration. Concentration: 1 mg/mL.
Rate: Administer the loading dose over 10 min.
Continuous Infusion: Dilution: Milrinone drawn from vials must be diluted. Dilute 10 mg (10 mL) of milrinone in 40 mL of diluent or 20 mg (20 mL) of milrinone in 80 mL of diluent. Compatible diluents include 0.45% NaCl, 0.9% NaCl, and D5W. Premixed infusions are already diluted and ready to use. Admixed solutions are stable for 72 hr at room temperature. Stability of premixed infusions based on manufacturer's expiration date. Do not use solutions that are discolored or contain particulate matter. Concentration: 200 mcg/mL.
Rate: Based on patient's weight (see Route/Dosage section). Titrate according to hemodynamic and clinical response.